Seidman AD - Search Results

1

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Seidman AD, Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg M, Bosl GJ. Seidman AD, et al. Cancer. 1991 Dec 15;68(12):2561-5. doi: 10.1002/1097-0142(19911215)68:12<2561::aid-cncr2820681205>3.0.co;2-g. Cancer. 1991. PMID: 1933802 Clinical Trial.

2

Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.

Seidman AD, Scher HI, Petrylak D, Dershaw DD, Curley T. Seidman AD, et al. J Urol. 1992 Mar;147(3 Pt 2):931-4. doi: 10.1016/s0022-5347(17)37426-8. J Urol. 1992. PMID: 1371564 Clinical Trial.

3

The evolving role of chemotherapy for muscle infiltrating bladder cancer.

Seidman AD, Scher HI. Seidman AD, et al. Semin Oncol. 1991 Dec;18(6):585-95. Semin Oncol. 1991. PMID: 1775975 Review.

4

Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Seidman AD, et al. J Natl Cancer Inst Monogr. 1993;(15):171-5. J Natl Cancer Inst Monogr. 1993. PMID: 7517153

5

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, et al. Seidman AD, et al. J Clin Oncol. 1995 May;13(5):1152-9. doi: 10.1200/JCO.1995.13.5.1152. J Clin Oncol. 1995. PMID: 7537798 Clinical Trial.

6

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.

Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al. Seidman AD, et al. J Natl Cancer Inst. 1995 Sep 6;87(17):1316-22. doi: 10.1093/jnci/87.17.1316. J Natl Cancer Inst. 1995. PMID: 7544834

7

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.

Seidman AD, Tiersten A, Hudis C, Gollub M, Barrett S, Yao TJ, Lepore J, Gilewski T, Currie V, Crown J, et al. Seidman AD, et al. J Clin Oncol. 1995 Oct;13(10):2575-81. doi: 10.1200/JCO.1995.13.10.2575. J Clin Oncol. 1995. PMID: 7595709 Clinical Trial.

8

Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.

Seidman AD, Scher HI, Gabrilove JL, Bajorin DF, Motzer RJ, O'Dell M, Curley T, Dershaw DD, Quinlivan S, Tao Y, et al. Seidman AD, et al. J Clin Oncol. 1993 Mar;11(3):408-14. doi: 10.1200/JCO.1993.11.3.408. J Clin Oncol. 1993. PMID: 7680373 Clinical Trial.

9

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, et al. Seidman AD, et al. Semin Oncol. 1993 Aug;20(4 Suppl 3):40-5. Semin Oncol. 1993. PMID: 7688145 Clinical Trial.

10

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

Reichman BS, Seidman AD, Crown JP, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, et al. Reichman BS, et al. Among authors: seidman ad. J Clin Oncol. 1993 Oct;11(10):1943-51. doi: 10.1200/JCO.1993.11.10.1943. J Clin Oncol. 1993. PMID: 7691998 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters